> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Congress Must Regulate CBD Since FDA Won’t: Steve Mister
- URL: https://www.fdaweb.com/congress-must-regulate-cbd-since-fda-wont-steve-mister/
- Published: 2021-09-09T12:00:00.000Z
- Updated: 2026-09-14T17:13:51.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5150113

Responding to an FDA objection to a new dietary ingredient notification submitted by Charlotte’s Web to demonstrate that its full-spectrum hemp extract is reasonably expected to be safe, Council for Responsible Nutrition CEO **Steve Mister** says Congress must step in and regulate the CBD (cannabidiol) marketplace. Mister appeared with Charlotte’s Web CEO **Deanie Elsner** in a “Short Legal Briefs” [video](https://www.naturalproductsinsider.com/regulatory/what-charlottes-webs-hemp-extract-ndi-filing-means-cbds-future?ref=fdaweb.com) posted by *Natural Products Insider*.

In the video, Elsner said she was disappointed in the way the agency made its decision to object to the notification for two reasons: that CBD products are excluded from the definition of a dietary supplement and that there were concerns about the sufficiency of the safety evidence.

She indicated that her company met multiple times with FDA officials before the notification was submitted to share data. The agency “ignored big parts of our application,” she said.

Mister said the FDA denial letter showed that the agency is not going to solve the problem with CBD and thus Congress must act. He said the industry should turn its attention to persuading Congress to intervene. Regulation is needed, he said, because reputable companies that are concerned about the quality of their products are stuck in a “quagmire” with other companies that are not as concerned about quality, and consumers are being hurt.